PolypDx™ is the first and only urine-based screening test with a high accuracy for detection of precancerous, adenomatous polyps. In a Canadian-based clinical trial of 1000 patients, PolypDx™ demonstrated significantly higher accuracy than current fecal-based screening test to detect adenomatous polyps.
Once screened, patients with a positive result and presenting a risk of adenomatous polyps can be directed to a colonoscopy during which the adenomatous polyps can be removed, thus preventing the progression into colorectal cancer. Those patients with negative results can continue with regular repeated screening with PolypDx™, and give themselves a peace of mind.